How the body handles huperzine A liquid in healthy people
This trial studies how the body processes a liquid form of huperzine A, a natural compound that may help memory and thinking, in healthy adults. By participating, you help researchers understand how the drug is absorbed and cleared from the body, which is important for future use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- Your Body Mass Index (BMI) is between 19 and 26.
- You are in good overall health without major chronic illnesses.
- You have no history of serious stomach or intestinal conditions.
- You are not currently taking any regular medications (except topical or eye drops).
- You are willing to follow the study restrictions on smoking, alcohol, and caffeine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This trial studies whether a medicine called huperzine A can reduce “postoperative delirium,” which is sudden confusion after surgery, in older adults. It focuses on people having non-heart surgery under general anesthesia for at least two hours.
This study tests whether Huperzine A controlled-release tablets can help improve memory and thinking in people with mild-to-moderate Alzheimer's disease. You'll take the tablets or a placebo to see if it slows down dementia symptoms.
This trial tests whether huperzine A can improve hearing-related symptoms along with tinnitus (ringing) and mild cognitive (memory/thinking) problems. If you have mild-to-moderate hearing loss plus bothersome constant tinnitus and some cognitive decline, this study may help researchers see if the treatment makes a difference.
This study tests an investigational drug called Huperzine A, given as an injection after treatment for a bleeding brain aneurysm, to see if it can help prevent or reduce thinking and memory problems that sometimes occur after surgery or procedures.
This study tests a new oral drug called ALZ-507, which is being developed for Alzheimer's disease. It is an early-phase trial to check the drug's safety and how it is processed in the body, in healthy older adults.
Hear when a new Healhty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.